Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer

被引:0
|
作者
Bidakhvidi, Niloefar Ahmadi [1 ,2 ]
Gevaert, Thomas [3 ]
De Schepper, Maxim [4 ]
Baldewijns, Marcella [4 ]
Havinga, Enrique [5 ]
Deckers, Wies [1 ]
Laenen, Annouschka [6 ]
Devos, Gaetan [3 ,7 ]
Giesen, Alexander [3 ,7 ]
Joniau, Steven [3 ,7 ]
Koole, Michel [1 ,2 ]
Everaerts, Wouter [7 ,8 ]
Deroose, Christophe M. [1 ,2 ]
Goffin, Karolien [1 ,2 ]
机构
[1] Univ Hosp Leuven, Nucl Med, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Dev & Regenerat, Urogenital Abdominal & Plast Surg, Leuven, Belgium
[4] Univ Hosp Leuven, Pathol, Leuven, Belgium
[5] Univ Hosp Leuven, Radiol, Leuven, Belgium
[6] Interuniv Inst Biostat & Stat Bioinformat, Leuven, Belgium
[7] Univ Hosp Leuven, Urol, Leuven, Belgium
[8] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Cellular & Mol Med, Leuven, Belgium
关键词
PSMA PET; PSMA immunohistochemistry; PET/MR; Parametric PET; Primary prostate cancer; IMMUNOREACTIVE SCORE; PET/CT; RECEPTORS; TISSUE; IRS;
D O I
10.1007/s00259-024-06903-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Quantification of PSMA expression via PSMA PET is well-established, however quantification of PSMA via immunohistochemistry (IHC) is not standardized. Our aim was to determine the most optimal PSMA IHC scoring system to quantify PSMA expression with PSMA PET as reference standard. Methods Primary intermediate- and high-risk prostate cancer patients received an [F-18]PSMA-1007 PET/MRI followed by radical prostatectomy. SUVmax, SUVmean and K-i of the prostate tumor was determined. Prostate tumors were stained with anti-PSMA antibodies and scored by 2 readers via 10 IHC scoring systems: histochemical score (H-score), immunoreactivity score(predominant intensity) (IRSpredominant intensity), IRS classification(predominant intensity), IRSmean intensity, IRS classification(mean intensity), Allred score, predominant expression pattern, Shannon diversity index (SDI), percentage negatively stained cells and total percentage positively stained cells. Spearman's rank correlation coefficients (rho) were calculated between PET parameters and IHC scoring systems. Interreader agreement for the IHC scoring systems was measured by the intraclass correlation coefficient (ICC). Results Fifty tumors in 46 patients were analysed. H-score had the best correlation with SUVmax (rho 0.615 p < 0.0001) and SUVmean (rho 0.570, p < 0.0001) and the second best correlation with Ki (rho 0.411, p = 0.0030). SDI had the best correlation with Ki (rho -0.440, p = 0.0014) and the second best correlation with SUVmax (rho -0.516, p = 0.0001) and SUVmean (rho -0.490, p = 0.0003). A moderate interreader agreement was observed for H-score (ICC 0.663, 95% CI 0.495-0.797) and SDI (ICC 0.546, 95% CI 0.354-0.725). Conclusion H-score had the best correlation with PSMA PET quantification and an acceptable interreader agreement. Therefore, we deem H-score the most optimal PSMA IHC scoring system.
引用
收藏
页码:766 / 778
页数:13
相关论文
共 50 条
  • [21] The cause of high [18F]PSMA-1007 uptake in the urinary bladder in some of the [18F]PSMA-1007 patients: an explorative, retrospective study
    Allach, Y.
    Prive, B.
    van Gemert, W.
    Schilham, M.
    Perk, L. R.
    Gotthardt, M.
    Nagarajah, J.
    Janssen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S530 - S530
  • [22] [18F]PSMA-1007 PET/CT findings in patient with the third oligometastatic brain recurrence of prostate cancer
    Khalimon, A.
    Antonevskaya, T.
    Atakishieva, L.
    Khodzhibekova, M.
    Leontyev, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S866 - S866
  • [23] Accuracy of Simultaneous F18 PSMA-1007 PET/ multiparametric Prostate MRI in Tumor Staging of Prostate Cancer
    Hussien, A.
    Kula, M.
    Ibrahim, W. H.
    Abd El-Gaid, S. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S483 - S483
  • [24] The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer
    Albano, Domenico
    Temponi, Alessandro
    Bertagna, Francesco
    Suardi, Nazareno
    Talin, Anna
    Bonu, Marco Lorenzo
    Triggiani, Luca
    ANNALS OF NUCLEAR MEDICINE, 2025,
  • [25] CLINICAL AND BIOCHEMICAL PREDICTORS OF [18F]PSMA-1007 PET IMAGING OF PROSTATE CANCER AT STAGING AND BIOCHEMICAL RECURRENCE
    Chikatamarla, A.
    Okano, S.
    Ansaldo, A.
    Jenvey, P.
    Thomas, P.
    Ramsay, S.
    Roberts, M.
    Pattison, D.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 12 - 12
  • [26] Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
    Tragardh, Elin
    Minarik, David
    Brolin, Gustav
    Bitzen, Ulrika
    Olsson, Bent
    Oddstig, Jenny
    EJNMMI PHYSICS, 2020, 7 (01)
  • [27] The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer, A Scoping Review
    Armany, David
    Vo, Lequang
    Self, Duncan
    Baskaranathan, Sriskanthan
    Hossack, Tania
    Bariol, Simon
    Ende, David
    Woo, Henry Hyunshik
    CANCERS, 2025, 17 (06)
  • [28] Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
    Hoffmann, Manuela A.
    von Eyben, Finn Edler
    Fischer, Nicolas
    Rosar, Florian
    Muller-Hubenthal, Jonas
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    CANCERS, 2022, 14 (06)
  • [29] A Robust [18F]-PSMA-1007 Radiomics Ensemble Model for Prostate Cancer Risk Stratification
    Pasini, Giovanni
    Stefano, Alessandro
    Mantarro, Cristina
    Richiusa, Selene
    Comelli, Albert
    Russo, Giorgio Ivan
    Sabini, Maria Gabriella
    Cosentino, Sebastiano
    Ippolito, Massimo
    Russo, Giorgio
    JOURNAL OF IMAGING INFORMATICS IN MEDICINE, 2024,
  • [30] An Explorative Study of the Incidental High Renal Excretion of [18F]PSMA-1007 for Prostate Cancer PET/CT Imaging
    Allach, Youssra
    Banda, Amina
    van Gemert, Willemijn
    de Groot, Michel
    Derks, Yvonne
    Schilham, Melline
    Hoepping, Alexander
    Perk, Lars
    Gotthardt, Martin
    Janssen, Marcel
    Nagarajah, James
    Prive, Bastiaan M.
    CANCERS, 2022, 14 (09)